Answers are grounded in this paper and cite their sources.
Separation of genomic and nongenomic vitamin D activities was achieved by structural modification of 1,25-dihydroxy vitamin D3 by introduction of 16 and 23E double bonds. The modified compound 3, lacking a 1 alpha-hydroxy group, exhibits only nongenomic activity. Its 1 alpha-hydroxy relative 4 expresses fully both genomic and non-genomic activities. A total synthesis of analogues 3 and 4 is described.
No takes yet. Share an insight, caveat, or question.
Kabat et al. (1998) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: